Drug profile · INN
pregabalin
APO-PREGABALIN
pregabalin (APO-PREGABALIN) is a voltage-gated calcium channel modulator. Associated with Viatris Pharmaceuticals Co.,. Route of administration: oral. Current US regulatory status: approved.
Drug details — pregabalin
- US status
- approved
- Class
- Nervous system (N02)
- Route
- ORAL
- Patents
- 2
- Programs
- 17
- Data quality
- 0.89
Quick answer
pregabalin (APO-PREGABALIN) is a voltage-gated calcium channel modulator. Associated with Viatris Pharmaceuticals Co.,. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Voltage-gated calcium channel modulator
Primary target: Voltage-gated calcium channel
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
| EMA | approved | — |
| TGA | approved | — |
| NMPA | clinical trials | — |
Pipeline programs
Related & competitor drugs
Related patents
Frequently asked questions
What is pregabalin?
pregabalin (APO-PREGABALIN) is a voltage-gated calcium channel modulator. Associated with Viatris Pharmaceuticals Co.,. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for pregabalin?
APO-PREGABALIN is a marketed brand name for pregabalin. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of pregabalin?
pregabalin has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.